BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37511629)

  • 21. Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
    Wang Z; Liu C
    PLoS One; 2021; 16(4):e0250603. PubMed ID: 33901239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway.
    Wang Q; Shi M; Sun S; Zhou Q; Ding L; Jiang C; Bian T; Jia F; Liu Y; Qin J
    Biochem Biophys Res Commun; 2020 Apr; 524(3):656-662. PubMed ID: 32033754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.
    Zhang XB; Song L; Wen HJ; Bai XX; Li ZJ; Ma LJ
    Tumour Biol; 2016 Jun; 37(6):8317-25. PubMed ID: 26729197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer.
    Li Q; Ge Y; Chen X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
    J Cell Biochem; 2019 Sep; 120(9):15190-15201. PubMed ID: 31021450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
    Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
    Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
    Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
    Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
    Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPAG5 Activates PI3K/AKT Pathway and Promotes the Tumor Progression and Chemo-Resistance in Gastric Cancer.
    An J; Yang L; Pan Y; He Y; Xie H; Tao Y; Li W; Yan Y; Chen S; Liu Y; Ma X; An L; Ji D; Su Z; Sheng J
    DNA Cell Biol; 2022 Oct; 41(10):893-902. PubMed ID: 36264549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
    Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
    Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway.
    Ao R; Guan L; Wang Y; Wang JN
    J Cell Biochem; 2018 Jun; 119(6):4420-4434. PubMed ID: 29143985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
    Tao Y; Sun C; Zhang T; Song Y
    Oncol Rep; 2017 Sep; 38(3):1806-1814. PubMed ID: 28731194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p.
    Mao Z; Wang Z; Zhang S; Pu Y; Wang J; Zhang T; Long Y; Liu Y; Ma Y; Zhu J
    Cancer Biomark; 2020; 29(2):245-253. PubMed ID: 32675391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer.
    Li H; Zhao S; Shen L; Wang P; Liu S; Ma Y; Liang Z; Wang G; Lv J; Qiu W
    Aging (Albany NY); 2021 Apr; 13(10):13626-13643. PubMed ID: 34091441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of LINC02465 Suppresses Gastric Cancer Cell Growth and Metastasis Via PI3K/AKT Pathway.
    Han L; Hao Y; Wang J; Wang Z; Yang H; Wu X
    Hum Gene Ther Clin Dev; 2019 Mar; 30(1):19-28. PubMed ID: 30632400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
    Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
    Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
    He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
    Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.
    Li L; Zhu X; Shou T; Yang L; Cheng X; Wang J; Deng L; Zheng Y
    Mol Med Rep; 2018 Mar; 17(3):4003-4010. PubMed ID: 29257342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
    Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
    EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [FJX1 overexpression is associated with poor prognosis and promotes gastric cancer proliferation
    Zhang H; Zhang Z; Wang Q; Wang L; Yang Z; Geng Z; Wang Y; Li J; Zuo L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):975-984. PubMed ID: 37439170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.